Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

Withdrawn before enrolling · Not applicable

Conditions studied: Coronary Artery Disease

In brief

The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.

Key facts

Study ID

NCT01584622

Run by

AUM Cardiovascular, Inc.

People needed

0

Starts

2012-07-01

Expected to finish

2013-02-01

Last updated by the study team

2013-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years old
• Willing and able to give informed consent
• Indicated for angiography evaluation.

You may not qualify if…

• Pregnant or nursing
• Presence of pacemaker/defibrillator
• Presence of artificial valve
• Presence of severe valve disease
• Presence of congenital heart defect
• Left Ventricular Assist Device (LVAD)
• Presence of a bypass graft
• Presence of scars on the site thorax areas
• Coarctation of the aorta
• Participation in trial within 30 days prior to collecting CADenceTM data
• Asthma with wheezing
• Inability to lie flat in the supine position
• Acute STEMI
• Heart Transplant
• Recent Cocaine Use

Where it is running

• Iowa Heart Center — Des Moines, Iowa, United States
• Mercy Hospital — Coon Rapids, Minnesota, United States
• Abbott/Minneapolis Heart Institute — Minneapolis, Minnesota, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Columbia University — New York, New York, United States
• Mt. Sinai — New York, New York, United States
• Cheyenne Vascular & Heart Institute — Cheyenne, Wyoming, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.